Skip to main content

Peer Review reports

From: Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis

Original Submission
11 Apr 2022 Submitted Original manuscript
30 Apr 2022 Author responded Author comments - Michihito Miyagi
Resubmission - Version 2
30 Apr 2022 Submitted Manuscript version 2
1 Jul 2022 Reviewed Reviewer Report
10 Jul 2022 Reviewed Reviewer Report
10 Jul 2022 Reviewed Reviewer Report
14 Jul 2022 Reviewed Reviewer Report - Xianghua Yi
16 Jul 2022 Reviewed Reviewer Report
18 Jul 2022 Reviewed Reviewer Report
20 Jul 2022 Reviewed Reviewer Report - Andrea Zuin
24 Aug 2022 Author responded Author comments - Michihito Miyagi
Resubmission - Version 3
24 Aug 2022 Submitted Manuscript version 3
25 Aug 2022 Reviewed Reviewer Report - Andrea Zuin
28 Aug 2022 Reviewed Reviewer Report
5 Sep 2022 Reviewed Reviewer Report
31 Oct 2022 Author responded Author comments - Michihito Miyagi
Resubmission - Version 4
31 Oct 2022 Submitted Manuscript version 4
Publishing
5 Nov 2022 Editorially accepted
29 Dec 2022 Article published 10.1186/s12890-022-02226-1

You can find further information about peer review here.

Back to article page